Scientists are using AI and physics-based simulations together to design new peptides that will kill previously ...
A prototype cell partly capable of replicating itself has been created using 36 existing bacterial genes, but it's not really ...
It is barely the second quarter of the year, yet the Kenyan healthcare regulatory landscape is being redrawn. Two documents released in 2026 will be major determinants of how pharmacies, clinics, ...
A team of researchers at the University of Warwick and Monash University has solved a puzzle that has stumped drug developers ...
The U.S. Food and Drug Administration selected three biopharma companies with manufacturing sites in North Carolina for a ...
FDA names companies domestic drug manufacturing pilot participants to enhance early regulatory engagement and streamline review processes.
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has ...
A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
The hospital-at-home (H@H) model — where patients receive acute level care in their homes, rather than in a hospital — has emerged as an innovative and promising approach to provide high quality care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results